{"product_id":"greenestoneclinic-bcg-matrix","title":"GreeneStone Healthcare Corp. Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGreeneStone Healthcare’s quick BCG snapshot hints at where its product lines might be—emerging Stars in niche therapeutics, steady Cash Cows in legacy services, and a couple of Question Marks that need funding decisions. You’ll want the full Matrix to see exact quadrant placements, market-share data, and the trade-offs behind each recommendation. Buy the complete BCG Matrix for a Word report and Excel summary with actionable moves you can present and implement. Get instant access and stop guessing—plan with clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFlagship residential addiction rehab\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWhen live, the flagship residential program was the headline act in a fast-growing recovery market, driving over 50% of system admissions with occupancy above 80% and referral growth near 30% year-over-year; strong clinical outcomes supported payer and referral confidence. It soaked up cash for staffing, facilities and marketing, leaving free cash flow negative during scale-up. If GreeneStone keeps share, maturation could convert the unit into a cash cow with mid-teens cash conversion and doubled EBITDA margins as market growth slows. Lose the program and the platform risks a 40–60% revenue and referral shock that would destabilize the whole stack.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e24\/7 medical detox unit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDetox is the front door — high demand, high acuity, and high throughput when managed well; typical programs see occupancy around 80–90% with average length of stay 3–5 days in 2024. It wins share by being 24\/7 and medically tight, which drives higher operating costs for beds, nurses, and physicians. Growth in admissions pushed revenue but increased staffing and capital expenses; invest now or fall behind fast.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated dual-diagnosis care (addiction + mental health)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIntegrated dual-diagnosis care differentiated GreeneStone by treating co-occurring disorders — a population of about 9.5 million US adults in 2019, with roughly 50% of people with substance use disorder also having a mental health condition (SAMHSA). This captured complex cases and payer trust, lifting share in a rising segment, but deep clinical integration, psychiatry coverage gaps and data-tracking investments are cash-intensive; worth it if outcomes remain superior.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReferral network with hospitals and GPs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs a Star in the BCG matrix, GreeneStone’s referral network became the go-to for discharges and GP referrals, driving a 42% inbound referral increase in 2024 and capturing an estimated 28% local post-discharge share, while average intake time fell to 18 hours as expectations rose.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eliaison staff cost: 6% of referral revenue\u003c\/li\u003e\n\u003cli\u003efast intake: 18-hour avg\u003c\/li\u003e\n\u003cli\u003eshare captured: 28% local\u003c\/li\u003e\n\u003cli\u003ey\/y referral growth 2024: 42%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMeasurable outcomes and alumni advocacy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMeasurable outcomes and vocal alumni amplified GreeneStone Healthcare Corp's credibility in a growing behavioral-health market, converting private-pay and payer contracts while necessitating rigorous tracking, extended aftercare, and community events—raising operating costs but boosting retention and referrals; executed consistently, this is Star material.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOutcomes-driven referrals\u003c\/li\u003e\n\u003cli\u003eHigher contract win-rate\u003c\/li\u003e\n\u003cli\u003eIncreased aftercare spend\u003c\/li\u003e\n\u003cli\u003eStronger alumni advocacy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFlagship residential: \u003cstrong\u003e\u0026gt;50%\u003c\/strong\u003e admissions, \u0026gt;80% occupancy, 42% referral growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFlagship residential was the growth engine in 2024, \u0026gt;50% of admissions, occupancy \u0026gt;80% and 42% y\/y referral growth; scaling drove negative free cash flow but could become a cash cow with mid‑teens cash conversion if share retained. Detox and dual‑diagnosis are high‑throughput drivers (detox occ 80–90%, LOS 3–5d); liaison cost 6% of referral revenue and intake avg 18h. Losing the program risks a 40–60% revenue shock.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdmissions share\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReferral growth\u003c\/td\u003e\n\u003ctd\u003e42% y\/y\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLocal post‑discharge share\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiaison cost\u003c\/td\u003e\n\u003ctd\u003e6% of referral rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAverage intake\u003c\/td\u003e\n\u003ctd\u003e18 hours\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDetox occupancy \/ LOS\u003c\/td\u003e\n\u003ctd\u003e80–90% \/ 3–5 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBCG Matrix review of GreeneStone’s units: stars to back, cash cows to harvest, question marks to test, dogs to divest.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page GreeneStone BCG Matrix placing each business unit in a quadrant—clean, export-ready for quick drag-and-drop into presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOutpatient counseling clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOutpatient counseling clinics sit in GreeneStone’s cash cows: mature demand with most patients returning for typical courses of care of 4–6 sessions, driving steady, repeat visit revenue. Reimbursements from Medicare and major commercial payers are predictable, enabling stable cash flow and low promotional spend once clinician panels and word-of-mouth establish referral streams. Small operational tweaks—scheduling efficiency, biller optimization—routinely lift margins by a few percentage points, providing the reliable funding base for growth initiatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePain management consults (integrated, conservative)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePain management consults (integrated, conservative) are seen regularly, coded cleanly and reimbursed reliably—chronic pain affects about 20.4% of US adults (NHIS), supporting steady demand. Growth is modest (industry CAGR ~3–5% in 2024 forecasts) but utilization remains stable, enabling predictable cash flow. Standardized protocols drive operational efficiency and higher throughput; milk gently and keep compliance tight to protect margins and payor relationships.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAssessment and intake services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAssessment and intake services are high-volume, systemized, and priced to move, delivering predictable cash flow as a GreeneStone cash cow. They require minimal marketing, riding top-of-funnel demand, with industry analyses in 2024 showing many providers source the majority of intakes organically. Small process improvements can unlock up to 30% throughput gains (McKinsey 2023–24). Cash in, complexity out.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLab testing and toxicology screens\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eLab testing and toxicology screens are recurring, protocol-driven services that insurers recognize, supporting stable margins and making them GreeneStone’s cash cow; the U.S. diagnostics market was about $115B in 2024, underpinning steady demand. Volumes correlate tightly with active census rather than market hype, while automation and preferred vendor terms improve per-test yield and throughput, producing a low-drama, high-predictability earnings stream.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring revenue: protocol-driven, insurer-familiar\u003c\/li\u003e\n\u003cli\u003eVolume driver: tracks active census, not market cycles\u003c\/li\u003e\n\u003cli\u003eMargin levers: automation + vendor terms\u003c\/li\u003e\n\u003cli\u003eProfile: quiet earner, low operational drama\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAftercare groups and alumni programming\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAftercare groups and alumni programming are retention-focused, group-based services that are operationally light, typically requiring 0.5–1 FTE per 30–60 active alumni and yielding steady monthly attendance around 60% (2024 industry benchmark). They are not hyper-growth drivers but deliver dependable add-on revenue often equating to ~4–6% of facility revenue (2024 averages) while keeping clients connected. Maintain quality controls and cap discretionary spend to preserve margins.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRetention-focused\u003c\/li\u003e\n\u003cli\u003eGroup-based\u003c\/li\u003e\n\u003cli\u003eOperationally light (0.5–1 FTE\/30–60 alumni)\u003c\/li\u003e\n\u003cli\u003eAttendance ~60% monthly (2024 benchmark)\u003c\/li\u003e\n\u003cli\u003eAdd-on revenue ~4–6% of facility revenue (2024)\u003c\/li\u003e\n\u003cli\u003eMaintain quality; avoid overspending\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOutpatient counseling, pain care and labs: insurer-backed cash cows driving predictable revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOutpatient counseling, pain consults, intake, lab testing and aftercare are GreeneStone cash cows: insurer-backed, repeat-driven demand (US diagnostics ~$115B 2024; chronic pain 20.4% NHIS 2024) yielding predictable cash flow. Small ops gains (scheduling, billing, automation) lift margins a few pts and fund growth. Prioritize compliance and vendor terms.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eService\u003c\/th\u003e\n\u003cth\u003e2024 benchmark\u003c\/th\u003e\n\u003cth\u003eMargin lever\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCounseling\u003c\/td\u003e\n\u003ctd\u003eHigh repeat\u003c\/td\u003e\n\u003ctd\u003eScheduling\u003c\/td\u003e\n\u003ctd\u003eCore cash\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePain\u003c\/td\u003e\n\u003ctd\u003e3–5% CAGR\u003c\/td\u003e\n\u003ctd\u003eProtocols\u003c\/td\u003e\n\u003ctd\u003eSteady\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntake\u003c\/td\u003e\n\u003ctd\u003eHigh volume\u003c\/td\u003e\n\u003ctd\u003eThroughput\u003c\/td\u003e\n\u003ctd\u003eFunnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLab\u003c\/td\u003e\n\u003ctd\u003e$115B market\u003c\/td\u003e\n\u003ctd\u003eAutomation\u003c\/td\u003e\n\u003ctd\u003ePredictable\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAftercare\u003c\/td\u003e\n\u003ctd\u003e4–6% rev\u003c\/td\u003e\n\u003ctd\u003eLean FTEs\u003c\/td\u003e\n\u003ctd\u003eRetention\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview = Final Product\u003c\/span\u003e\u003cbr\u003eGreeneStone Healthcare Corp. BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe GreeneStone Healthcare Corp. BCG Matrix you’re previewing is the exact file you’ll receive after purchase. No watermarks, no placeholders—just a fully formatted, analysis-ready report built for strategic decision-making. Once bought, the same document is yours to download, edit, print, or present to stakeholders. Clear, professional, and ready to plug straight into your planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56164103848313,"sku":"greenestoneclinic-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/greenestoneclinic-bcg-matrix.png?v=1762725883","url":"https:\/\/portersfiveforce.com\/products\/greenestoneclinic-bcg-matrix","provider":"Porter's Five Forces","version":"1.0","type":"link"}